Tag: PACK-CXL

The Antibacterial Efficacy of High-Fluence PACK Cross-Linking Can Be Accelerated

The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can be accelerated while still maintaining its antibacterial efficacy. The study found that high-fluence PACK-CXL did indeed decrease the bacterial concentration of several clinically significant bacterial strains, including S. aureus, P. aeruginosa, and S. epidermidis. These strains are commonly implicated in bacterial keratitis and contact lens-associated keratitis. Furthermore, the authors found that higher total fluence PACK-CXL protocols led to a corresponding increase in bacterial killing ratio (BKR).

What is the future of CXL?

Corneal cross-linking (CXL) has been used in the clinic for over 20 years now, but if you ever wanted to know what the future of

2021 advances in cross-linking

Speaker: Prof. Farhad Hafezi, ELZA Institute
Meeting: Hellenic Society for Intraocular Implants and Refractive Surgery (HSIOIRS)
Date: March 2021
Language: English
 
Summary: Prof. Hafez gives on overview about the current state of CXL technology at the annual Hellenic HSOIRS meeting 2021

CXL at the slit lamp: clinical experience & application

Speaker: Prof. Farhad Hafezi, ELZA Institute
Meeting: CSO Italia Webinar. Innovative Ophthalmology
Date: February 2021
Language: English
 
Summary: Prof. Farhad Hafezi from the ELZA Institute in Switzerland explains corneal cross-linking for keratoconus and keratitis at the slit lamp.